Carroll Financial Associates’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $412K | Sell |
1,563
-56
| -3% | -$13.9K | 0.02% | 274 |
|
|
2021
Q3 | $391K | Buy |
1,619
+27
| +2% | +$6.8K | 0.02% | 275 |
|
|
2021
Q2 | $377K | Hold |
1,592
| – | – | 0.02% | 289 |
|
|
2021
Q1 | $348K | Sell |
1,592
-27
| -2% | -$5.42K | 0.02% | 292 |
|
|
2020
Q4 | $283K | Buy |
1,619
+27
| +2% | +$4.66K | 0.02% | 309 |
|
|
2020
Q3 | $257K | Hold |
1,592
| – | – | 0.02% | 304 |
|
|
2020
Q2 | $227K | Hold |
1,592
| – | – | 0.02% | 316 |
|
|
2020
Q1 | $172K | Hold |
1,592
| – | – | 0.02% | 324 |
|
|
2019
Q4 | $231K | Hold |
1,592
| – | – | 0.02% | 328 |
|
|
2019
Q3 | $229K | Hold |
1,592
| – | – | 0.02% | 333 |
|
|
2019
Q2 | $236K | Buy |
1,592
+137
| +9% | +$19.1K | 0.02% | 322 |
|
|
2019
Q1 | $191K | Hold |
1,455
| – | – | 0.02% | 331 |
|
|
2018
Q4 | $158K | Hold |
1,455
| – | – | 0.02% | 296 |
|
|
2018
Q3 | $217K | Hold |
1,455
| – | – | 0.02% | 270 |
|
|
2018
Q2 | $224K | Buy |
1,455
+116
| +9% | +$17.5K | 0.02% | 262 |
|
|
2018
Q1 | $186K | Hold |
1,339
| – | – | 0.02% | 278 |
|
|
2017
Q4 | $183K | Sell |
1,339
-5
| -0.4% | -$661 | 0.02% | 279 |
|
|
2017
Q3 | $175K | Buy |
1,344
+5
| +0.4% | +$667 | 0.02% | 284 |
|
|
2017
Q2 | $177K | Hold |
1,339
| – | – | 0.02% | 283 |
|
|
2017
Q1 | $164K | Hold |
1,339
| – | – | 0.02% | 284 |
|
|
2016
Q4 | $147K | Hold |
1,339
| – | – | 0.02% | 285 |
|
|
2016
Q3 | $158K | Hold |
1,339
| – | – | 0.02% | 268 |
|
|
2016
Q2 | $149K | Hold |
1,339
| – | – | 0.02% | 274 |
|
|
2016
Q1 | $134K | Hold |
1,339
| – | – | 0.02% | 272 |
|
|
2015
Q4 | $142K | Sell |
1,339
-38
| -3% | -$3.92K | 0.03% | 242 |
|
|
2015
Q3 | $137K | Hold |
1,377
| – | – | 0.03% | 239 |
|
|
2015
Q2 | $143K | Hold |
1,377
| – | – | 0.03% | 230 |
|
|
2015
Q1 | $149K | Hold |
1,377
| – | – | 0.07% | 157 |
|
|
2014
Q4 | $138K | Hold |
1,377
| – | – | 0.09% | 139 |
|
|
2014
Q3 | $118K | Sell |
1,377
-136
| -9% | -$12.3K | 0.04% | 196 |
|
|
2014
Q2 | $133K | Hold |
1,513
| – | – | 0.04% | 199 |
|
|
2014
Q1 | $128K | Hold |
1,513
| – | – | 0.04% | 190 |
|
|
2013
Q4 | $118K | Hold |
1,513
| – | – | 0.04% | 190 |
|
|
2013
Q3 | $128K | Sell |
1,513
-23
| -1% | -$1.94K | 0.05% | 181 |
|
|
2013
Q2 | $132K | Buy |
+1,536
| New | +$128K | 0.06% | 136 |
|
Other funds holding LH
MCM
Carroll Financial Associates's LH Position: Q4 2021 in Review
Carroll Financial Associates reduced its Labcorp (LH) stake by 3.5% in Q4 2021, selling an estimated $13.9K and leaving 1,563 shares worth $412K. The position accounts for 0.02% of the portfolio, ranked #274.
Carroll Financial Associates first reported a position in LH in Q2 2013 and has held it in 35 quarters since. 1,061 funds tracked by Wall St. Rank hold LH as of Q4 2021.
- Carroll Financial Associates held 1,563 shares of Labcorp worth $412K as of Q4 2021.
- Carroll Financial Associates sold 56 Labcorp shares in Q4 2021, an estimated $13.9K.
- Labcorp made up 0.02% of Carroll Financial Associates's portfolio in Q4 2021, its #274 holding.
- Carroll Financial Associates first reported a position in Labcorp in Q2 2013 and has held it in 35 quarters since.
- 1,061 funds tracked by Wall St. Rank held Labcorp as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.